COVID-19

New and Noteworthy

Poll: Most Adults Do Not Expect to Get a COVID-19 Shot This Fall; Many Parents Confused About Recommendations for Children

As federal vaccine policy changes, this poll finds that most adults do not expect to get a COVID-19 vaccine this fall , and many parents are confused and uncertain about whether the vaccine is recommended for healthy children this year. About one in adults nationally say the changes to vaccine policy are making people safer, while more than a third say they are making people less safe.

ACIP, CDC, and Insurance Coverage of Vaccines in the United States

This brief provides an overview of vaccine coverage requirements by payer or program, as they relate to the Advisory Committee on Immunization Practices (ACIP) and the Centers for Disease Control and Prevention (CDC). Currently, private insurers, Medicare, and Medicaid require no-cost coverage of vaccines—a requirement connected to recommendations made by ACIP and the CDC. If these recommendations are narrowed or removed, people could have to pay for vaccines out of pocket going forward.

Additional Resources

Global COVID-19 Tracker

This tracker provides the number of cases and deaths from novel coronavirus by country, the trend in case and death counts by country, and a global map of showing which countries have cases and deaths.

COVID-19 and Related State Data

Use this tool to create custom reports of COVID-19 and related state data. Group COVID-19 cases and deaths with indicators like total hospitalizations, vaccinations and mental illness.

Subscribe to KFF Emails

Choose which emails are best for you.
Sign up here

Filter

1 - 10 of 768 Results

  • The Problem Isn’t Trust in Vaccines, It’s That People Don’t Know Who to Trust

    From Drew Altman

    In a new “Beyond the Data” column, KFF’s President and CEO Dr. Drew Altman analyzes years of KFF polling on vaccines in light of the current controversies about them. The real problem, he says, is not lack of public confidence in the safety of vaccines — few say they are unsafe — it’s that polarization and misinformation have eroded confidence in what’s true or not, and in scientific institutions people used to rely on for the facts.

  • How Could FDA’s New Guidance Affect COVID-19 Vaccination Coverage in the U.S.?

    Quick Take

    Taken together, the new guidance on clinical trial requirements, the more restricted approval of the Novavax vaccine, and anticipated changes to CDC recommendations add up to fewer Americans eligible for COVID-19 vaccines and more limited access to these vaccines compared to previous years...such a shift would place the U.S. more in line with Australia, Canada, and countries in Europe.

  • U.S. Measles Outbreaks: A New Abnormal in a Time of Vaccine Hesitancy

    Quick Take

    Given the current trends and embrace of vaccine skepticism on the part of the administration, and potential changes to federal policy around childhood vaccines, we might continue to witness more and longer outbreaks of preventable disease — and just maybe lose our measles elimination status, which as a country we’ve had for 25 years.

  • What Drives Differences in Life Expectancy between the U.S. and Comparable Countries?

    Issue Brief

    This analysis compares 2021 data about deaths in the U.S. and 11 other large, wealthy countries by age and cause to understand the primary drivers of the longevity gap between the U.S. and the comparable countries. It finds that the primary reasons for the gap in 2021 were chronic disease, COVID-19 and substance use disorders.

  • How Does U.S. Life Expectancy Compare to Other Countries?

    Feature

    This chart collection examines how life expectancy in the U.S. compares to that of other similarly large and wealthy countries. Between 2019 and 2022, the U.S. experienced a sharper decline and a slower rebound in life expectancy than peer countries, on average, due to increased mortality and premature death rates in the U.S. from the COVID-19 pandemic. In 2023, life expectancy in the U.S. returned to pre-pandemic levels, but remains lower than that of comparable countries.